Researchers Are Hatching a Low-Cost Coronavirus Vaccine – Money Control via The New York Times

Read article - Continued coverage of comments by former Geisel School of Medicine faculty member Jason McLellan in an article about a new COVID-19 vaccine entering clinical trials in several countries. Research that McLellan conducted at Geisel prior to the pandemic contributed to the development of COVID-19 vaccines. At the University of Texas, he helped develop the spike protein HexaPro, a key element of the new NDV-HXP-S vaccine.